Current evidence of COVID-19 vaccination-related cardiovascular events

References

• World Health Organization (WHO). WHO Coronavirus (COVID-19) Dashboard 2022. 2022. cited 2022 Dec 12]. Available from: https://covid19.who.int/?adgroupsurvey={adgroupsurvey}&gclid=CjwKCAiAv9ucBhBXEiwA6N8nYPrrcEkx_QiUs7bNQ3KQQ1ELdn6wWMoN65taYosxOPCOHOUBxBdPRBoCxUkQAvD_BwE
   Google Scholar
• Hu B, Guo H, Zhou P, et al. Characteristics of SARS-CoV-2 and COVID-19. Nature Rev Microbiol. 2021;19(3):141–154.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). COVID Data Tracker. 2022. [Accessed 10 December 2022]. Available from: https://covid.cdc.gov/covid-data-tracker/#datatracker-home
   Google Scholar
• Malik JA, Ahmed S, Mir A, et al. The SARS-CoV-2 mutations versus vaccine effectiveness: new opportunities to new challenges. J Infect Public Health. 2022;15(2):228–240. PubMed PMID: 35042059; PubMed Central PMCID: PMCPMC8730674; Eng.
   PubMed Web of Science ®Google Scholar
• Dyer O. Covid-19: unvaccinated face 11 times risk of death from delta variant, CDC data show. BMJ. 2021;374(2282). DOI:10.1136/bmj.n2282
   Web of Science ®Google Scholar
• Su JR, McNeil MM, Welsh KJ, et al. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018. Vaccine. 2021;39(5):839–845. PubMed PMID: 33422381; Eng.
   PubMed Web of Science ®Google Scholar
• Parmar K, Subramanyam S, Del Rio-Pertuz G, et al. Cardiac Adverse Events after Vaccination— a Systematic Review. Vaccines (Basel). 2022;10(5):700.
   PubMed Web of Science ®Google Scholar
• Vaccine Adverse Event Report System (VAERS). In: United States Department of Health and Human Services (DHHS) PHSP, Centers for Disease Control (CDC)/Food and Drug Administration (FDA), Vaccine Adverse Event Reporting System (VAERS), editor. CDC wonder on-line database. 2022. [cited 2022 May 23]. Available from: http://wonder.cdc.gov/vaers.html
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Selected Adverse Events Reported after COVID-19 Vaccination. 2022. cited 2022 Dec 04]: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html
   Google Scholar
• Pires C. Global Predictors of COVID-19 Vaccine Hesitancy: a Systematic Review. Vaccines (Basel). 2022;10(8): PubMed PMID: 36016237; PubMed Central PMCID: PMCPMC9415631; Eng. DOI:10.3390/vaccines10081349.
   Web of Science ®Google Scholar
• Xie Y, Xu E, Bowe B, et al. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583–590.
   PubMed Web of Science ®Google Scholar
• Vardell E, Malloy M. Joanna Briggs Institute: an Evidence-Based Practice Database. Med Ref Serv Q. 2013;32(4):434–442.
   PubMedGoogle Scholar
• Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158–3176.
   PubMed Web of Science ®Google Scholar
• Starekova J, Bluemke DA, Bradham WS, et al. Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol. 2021;6(8):945–950.
   PubMed Web of Science ®Google Scholar
• Mevorach D, Anis E, Cedar N, et al. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel. N Engl J Med. 2021;385(23):2140–2149. PubMed PMID: 34614328.
   PubMed Web of Science ®Google Scholar
• Ammirati E, Cavalotti C, Milazzo A, et al. Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection. Int J Cardiol Heart Vasc. 2021;34:100774. PubMed PMID: 33821210; Eng.
   PubMed Web of Science ®Google Scholar
• Marshall M, Ferguson ID, Lewis P, et al. symptomatic acute myocarditis in 7 adolescents after pfizer-BioNTech COVID-19 Vaccination. Pediatrics. 2021;148(3). PubMed PMID: 34088762; Eng. DOI:10.1542/peds.2021-052478.
   PubMed Web of Science ®Google Scholar
• Kim HW, Jenista ER, Wendell DC, et al. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. JAMA Cardiol. 2021;6(10):1196–1201.
   PubMed Web of Science ®Google Scholar
• Diaz GA, Parsons GT, Gering SK, et al. Myocarditis and pericarditis after vaccination for COVID-19. JAMA. 2021;326(12):1210–1212.
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Kamat I, Hotez PJ. Myocarditis With COVID-19 mRNA Vaccines. Circulation. 2021;144(6):471–484. PubMed PMID: 34281357; PubMed Central PMCID: PMCPMC8340726; Eng.
   PubMed Web of Science ®Google Scholar
• Goddard K, Hanson KE, Lewis N, et al. Incidence of myocarditis/pericarditis following mRNA COVID-19 vaccination among children and younger adults in the United States. Ann Intern Med. 2022;175(12):1169–1771. PubMed PMID: 36191323; PubMed Central PMCID: PMCPMC9578536; Eng.
   PubMed Web of Science ®Google Scholar
• Ho JS, Sia CH, Ngiam JN, et al. A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore Med J. 2021. DOI:10.11622/smedj.2021210. PubMed PMID: 34808708; Eng.
   Web of Science ®Google Scholar
• United States Food and Drug Administration (FDA). Vaccines and related biological products advisory committee meeting. 2022. cited 2022 Dec 03]: https://www.fda.gov/media/158912/download
   Google Scholar
• Patone M, Mei XW, Handunnetthi L, et al. Risk of myocarditis after sequential doses of COVID-19 Vaccine and SARS-CoV-2 infection by age and sex. Circulation. 2022;146(10):743–754.
   PubMed Web of Science ®Google Scholar
• Buchan SA, Seo CY, Johnson C, et al. Epidemiology of myocarditis and pericarditis following mRNA vaccination by vaccine product, schedule, and interdose interval among adolescents and adults in Ontario, Canada. JAMA Network Open. 2022;5(6):e2218505–e2218505.
   PubMed Web of Science ®Google Scholar
• Andrews N, Stowe J, Kirsebom F, et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) Variant. N Engl J Med. 2022;386(16):1532–1546.
   PubMed Web of Science ®Google Scholar
• Nemet I, Kliker L, Lustig Y, et al. Third BNT162b2 vaccination Neutralization of SARS-CoV-2 Omicron Infection. N Engl J Med. 2022;386(5):492–494. PubMed PMID: 34965337; PubMed Central PMCID: PMCPMC8823651; Eng.
   PubMed Web of Science ®Google Scholar
• Goddard K, Lewis N, Fireman B, et al. Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination. Vaccine. 2022;40(35):5153–5159. PubMed PMID: 35902278; PubMed Central PMCID: PMCPMC9273527; Eng.
   PubMed Web of Science ®Google Scholar
• DeSilva M, Haapala J, Vazquez-Benitez G, et al. Evaluation of acute adverse events after Covid-19 vaccination during pregnancy. N Engl J Med. 2022;387(2):187–189. PubMed PMID: 35731916; PubMed Central PMCID: PMCPMC9258750; Eng.
   PubMed Web of Science ®Google Scholar
• Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet (London, England). 2012;379(9817):738–747. doi:10.1016/S0140-6736(11)60648-X. PubMed PMID: 22185868; PubMed Central PMCID: PMCPMC5814111; Eng.
   PubMed Web of Science ®Google Scholar
• Kounis NG, Koniari I, Mplani V, et al. Hypersensitivity Myocarditis and the Pathogenetic Conundrum of COVID-19 Vaccine-Related Myocarditis. Cardiology. 2022;147(4):413–415.
   PubMed Web of Science ®Google Scholar
• Hajjo R, Sabbah DA, Bardaweel SK, et al. Shedding the light on post-vaccine myocarditis and Pericarditis in COVID-19 and Non-COVID-19 vaccine recipients. Vaccines (Basel). 2021;9(10):1186. PubMed PMID: 34696294; Eng.
   PubMed Web of Science ®Google Scholar
• Al-Ali D, Elshafeey A, Mushannen M, et al. Cardiovascular and haematological events post COVID-19 vaccination: a systematic review. J Cell Mol Med. 2022;26(3):636–653.
   PubMed Web of Science ®Google Scholar
• Fatima M, Ahmad Cheema H, Ahmed Khan MH, et al. Development of myocarditis and pericarditis after COVID-19 vaccination in adult population: a systematic review. Ann Med Surg (Lond). 2022;76:103486. PubMed PMID: 35291413; PubMed Central PMCID: PMCPMC8912977; Eng.
   PubMed Web of Science ®Google Scholar
• Schauer J, Buddhe S, Colyer J, et al. Myopericarditis after the pfizer messenger ribonucleic acid coronavirus disease vaccine in adolescents. J Pediatr. 2021;238:317–320. PubMed PMID: 34228985; Eng.
   PubMed Web of Science ®Google Scholar
• Fronza M, Thavendiranathan P, Chan V, et al. Myocardial injury pattern at MRI in COVID-19 vaccine-associated myocarditis. Radiology. 2022;304(3):553–562. PubMed PMID: 35166587; Eng.
   PubMed Web of Science ®Google Scholar
• Haussner W, DeRosa AP, Haussner D, et al. COVID-19 associated myocarditis: a systematic review. Am J Emerg Med. 2022;51:150–155. PubMed PMID: 34739868; PubMed Central PMCID: PMCPMC8531234; Eng.
   PubMed Web of Science ®Google Scholar
• Heidecker B, Dagan N, Balicer R, et al. Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the heart failure association of the European Society of Cardiology (ESC) and the ESC working group on myocardial and pericardial diseases. Eur J Heart Fail. 2022;24(11):2000–2018. PubMed PMID: 36065751; PubMed Central PMCID: PMCPMC9538893; Eng.
   PubMed Web of Science ®Google Scholar
• Li M, Yuan J, Lv G, et al. Myocarditis and Pericarditis following COVID-19 Vaccination: inequalities in Age and Vaccine Types. J Pers Med. 2021;11(11):1106. PubMed PMID: 34834458; PubMed Central PMCID: PMCPMC8624452; Eng.
   PubMed Web of Science ®Google Scholar
• Matta A, Kunadharaju R, Osman M, et al. Clinical presentation and outcomes of myocarditis post mRNA vaccination: a meta-analysis and systematic review. Cureus. 2021;13(11):e19240. PubMed PMID: 34877217; PubMed Central PMCID: PMCPMC8641964; Eng.
   PubMed Web of Science ®Google Scholar
• McLean K, Johnson TJ. Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: a case report. Acad Emerg Med. 2021;28(8):918–921. PubMed PMID: 34133825; PubMed Central PMCID: PMCPMC8441784; Eng.
   PubMed Web of Science ®Google Scholar
• Minocha PK, Better D, Singh RK, et al. Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. J Pediatr. 2021;238:321–323. PubMed PMID: 34166671; Eng.
   PubMed Web of Science ®Google Scholar
• Abu Mouch S, Roguin A, Hellou E, et al. Myocarditis following COVID-19 mRNA vaccination. Vaccine. 2021;39(29):3790–3793. PubMed PMID: 34092429; PubMed Central PMCID: PMCPMC8162819; Eng.
   PubMed Web of Science ®Google Scholar
• Das BB, Moskowitz WB, Taylor MB, et al. Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: what Do We Know So Far? Children. 2021;8(7):10.3390/children8070607. PubMed PMID: 34356586; PubMed Central PMCID: PMCPMC8305058; Eng.
   Google Scholar
• Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021;384(22):2092–2101. PubMed PMID: 33835769; PubMed Central PMCID: PMCPMC8095372; Eng.
   PubMed Web of Science ®Google Scholar
• See I, Lale A, Marquez P, et al. Case series of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination-United States, December 2020 to August 2021. Ann Intern Med. 2022;175(4):513–522. PubMed PMID: 35038274; PubMed Central PMCID: PMCPMC8787833; Eng.
   PubMed Web of Science ®Google Scholar
• Thaler J, Ay C, Gleixner KV, et al. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). J Thromb Haemost. 2021;19(7):1819–1822. PubMed PMID: 33877735; PubMed Central PMCID: PMCPMC8362082; Eng.
   PubMed Web of Science ®Google Scholar
• Patriquin CJ, Laroche V, Selby R, et al. Therapeutic plasma exchange in vaccine-induced immune thrombotic thrombocytopenia. N Engl J Med. 2021;385(9):857–859. PubMed PMID: 34233107; PubMed Central PMCID: PMCPMC8279091; Eng.
   PubMed Web of Science ®Google Scholar
• Bussel JB, Connors JM, Cines DB, et al. Vaccine-induced immune thrombotic thrombocytopenia. In: American Society of Hematology, editor. The Diagnosis and Management of TTS (VITT). 2022. [Accessed 10 December 2022] Available from: https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia
   Google Scholar
• Warkentin T, Cuker A. COVID-19: vaccine-induced immune thrombotic thrombocytopenia (VITT). In: Crowther M, editor. UpToDate. 2022. [Accessed 10 December 2022]. Available from: https://www.uptodate.com/contents/covid-19-vaccine-induced-immune-thrombotic-thrombocytopenia-vitt
   Google Scholar
• United States Food and Drug administration (FDA). Janssen COVID-19 Vaccine. 2022. cited 2022 Dec 02]: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19-vaccine
   Google Scholar
• Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078–1090. PubMed PMID: 34432976; PubMed Central PMCID: PMCPMC8427535; Eng.
   PubMed Web of Science ®Google Scholar
• Jabagi MJ, Botton J, Bertrand M, et al. Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older. JAMA. 2022;327(1):80–82.
   PubMed Web of Science ®Google Scholar
• Klein NP, Lewis N, Goddard K, et al. Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA. 2021;326(14):1390–1399.
   PubMed Web of Science ®Google Scholar
• Greinacher A, Gopinadhan M, Günther JU, et al. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies. Arterioscler Thromb Vasc Biol. 2006;26(10):2386–2393. PubMed PMID: 16873726; Eng.
   PubMed Web of Science ®Google Scholar
• Alam W. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review of the potential mechanisms and proposed management. Sci Prog. 2021;104(2):368504211025927. PubMed PMID: 34120531; Eng.
   PubMed Web of Science ®Google Scholar
• Greinacher A, Schönborn L, Siegerist F, et al. Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT). Semin Hematol. 2022;59(2):97–107. PubMed PMID: 35512907; PubMed Central PMCID: PMCPMC8863951; Eng.
   PubMed Web of Science ®Google Scholar
• Greinacher A, Selleng K, Palankar R, et al. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Blood. 2021;138(22):2256–2268. PubMed PMID: 34587242; PubMed Central PMCID: PMCPMC8483989; Eng.
   PubMed Web of Science ®Google Scholar
• Arepally GM, Ortel TL. Heparin-induced thrombocytopenia. Annu Rev Med. 2010;61(1):77–90. PubMed PMID: 20059332; PubMed Central PMCID: PMCPMC4153429; Eng.
   PubMed Web of Science ®Google Scholar
• Kvien TK, Uhlig T, Ødegård S, et al. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci. 2006;1069(1):212–222. PubMed PMID: 16855148; Eng.
   PubMed Web of Science ®Google Scholar
• MacNeil JR, Su JR, Broder KR, et al. Updated recommendations from the Advisory Committee on Immunization Practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients—United States. Morbidity and Mortality Weekly Report2021. 2021 April;70(17):651.
   Google Scholar
• Schultz NH, Sørvoll IH, Michelsen AE, et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021;384(22):2124–2130. PubMed PMID: 33835768; PubMed Central PMCID: PMCPMC8112568; Eng.
   PubMed Web of Science ®Google Scholar
• Pavord S, Scully M, Hunt BJ, et al. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. N Engl J Med. 2021;385(18):1680–1689.
   PubMed Web of Science ®Google Scholar
• Scully M, Singh D, Lown R, et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021;384(23):2202–2211. PubMed PMID: 33861525; PubMed Central PMCID: PMCPMC8112532; Eng.
   PubMed Web of Science ®Google Scholar
• Kounis NG, Koniari I, de Gregorio C, et al. COVID-19 disease, women’s predominant non-heparin vaccine-induced thrombotic thrombocytopenia and kounis syndrome: a passepartout cytokine storm interplay. Biomedicines. 2021;9(8):959.
   PubMed Web of Science ®Google Scholar
• Ahmed I, Majeed A, Powell R. Heparin induced thrombocytopenia: diagnosis and management update. Postgrad Med J. 2007;83(983):575–582. Eng.
   PubMed Web of Science ®Google Scholar
• Kiefel V, Greinacher A. Differential diagnosis and treatment of thrombocytopenia. Internist (Berl). 2010;51(11):1397–1410. PubMed PMID: 20941473. Ger.
   PubMed Web of Science ®Google Scholar
• International Society on Thrombosis and Haemostasis (ISTH). ISTH Interim Guidance for the Diagnosis and Treatment on VaccineInduced Immune Thrombotic Thrombocytopenia. 2021. cited 2022 Dec 04]: https://www.isth.org/news/561406/The-ISTH-Releases-Interim-Guidance-on-Vaccine-Induced-Immune-Thrombotic-Thrombocytopenia-VITT-.htm
   Google Scholar
• Aye YN, Mai AS, Zhang A, et al. Acute Myocardial Infarction and Myocarditis following COVID-19 Vaccination. QJM. 2021. DOI:10.1093/qjmed/hcab252. PubMed PMID: 34586408; PubMed Central PMCID: PMCPMC8522388; Eng.
   PubMed Web of Science ®Google Scholar
• Pottegård A, Lund LC, Karlstad Ø, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ. 2021;373(1114). PubMed PMID: 33952445; PubMed Central PMCID: PMCPMC8097496; Eng. DOI:10.1136/bmj.n1114.
   PubMed Web of Science ®Google Scholar
• Ritter O, Bonz A, Strotmann J, et al. Myocardial infarction after influenza vaccination. Zeitschrift fur Kardiologie. 2003;92(11):962–965. PubMed PMID: 14634767. Ger.
   PubMedGoogle Scholar
• Stone CA Jr., Rukasin CRF, Beachkofsky TM, et al. Immune-mediated adverse reactions to vaccines. Br J Clin Pharmacol. 2019;85(12):2694–2706. PubMed PMID: 31472022; PubMed Central PMCID: PMCPMC6955412; Eng.
   PubMed Web of Science ®Google Scholar
• Maadarani O, Bitar Z, Shoeb S, et al. From wellens to kounis syndrome: an unlucky patient. European journal of case reports in internal medicine. 2020;7(9):001689. PubMed PMID: 32908826; PubMed Central PMCID: PMCPMC7473679; Eng
   Google Scholar
• Boivin Z, Martin J. Untimely Myocardial Infarction or COVID-19 Vaccine Side Effect. Cureus. 2021;13(3):e13651. PubMed PMID: 33824804; PubMed Central PMCID: PMCPMC8012173; Eng.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Ojha UK, Vardhan B, et al. Myocardial infarction after COVID-19 vaccination-casual or causal? Diabetes Metab Syndr. 2021;15(3):1055–1056. PubMed PMID: 33888439; Eng.
   PubMed Web of Science ®Google Scholar
• Lee E, Chew NWS, Ng P, et al. A spectrum of cardiac manifestations post Pfizer-BioNTech COVID-19 vaccination. QJM. 2021;114(9):661–662. PubMed PMID: 34191024; Eng.
   PubMed Web of Science ®Google Scholar
• Bardenheier BH, Gravenstein S, Blackman C, et al. Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents. Vaccine. 2021;39(29):3844–3851. PubMed PMID: 34092431; PubMed Central PMCID: PMCPMC8162901; Eng.
   PubMed Web of Science ®Google Scholar
• Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384(5):403–416. PubMed PMID: 33378609; PubMed Central PMCID: PMCPMC7787219; Eng.
   PubMed Web of Science ®Google Scholar
• Logunov DY, Dolzhikova IV, Shcheblyakov DV, et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397(10275):671–681.
   PubMed Web of Science ®Google Scholar
• Tanriover MD, Doganay HL, Akova M, et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet. 2021;398(10296):213–222. (London England). PubMed PMID: 34246358; PubMed Central PMCID: PMCPMC8266301; Eng
   PubMed Web of Science ®Google Scholar
• Aiba T, Ishibashi K, Hattori K, et al. Frequent premature ventricular contraction and non-sustained ventricular tachycardia after the SARS-CoV-2 vaccination in patient with implantable cardioverter defibrillator due to acquired long-QT syndrome. Circ J. 2021;85(11):2117. PubMed PMID: 34275963; Eng.
   PubMed Web of Science ®Google Scholar
• Patone M, Mei XW, Handunnetthi L, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022;28(2):410–422. PubMed PMID: 34907393; PubMed Central PMCID: PMCPMC8863574; Eng.
   PubMed Web of Science ®Google Scholar
• Sadoff J, Gray G, Vandebosch A, et al. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. N Engl J Med. 2021;384(23):2187–2201. PubMed PMID: 33882225.
   PubMed Web of Science ®Google Scholar
• Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111.
   PubMed Web of Science ®Google Scholar
• Hatch F, Lancaster MK, Jones SA. Aging is a primary risk factor for cardiac arrhythmias: disruption of intracellular Ca2+ regulation as a key suspect. Expert Rev Cardiovasc Ther. 2011;9(8):1059–1067. PubMed PMID: 21878050; Eng.
   PubMedGoogle Scholar
• Jeet Kaur R, Dutta S, Charan J, et al. Cardiovascular Adverse Events Reported from COVID-19 Vaccines: a Study Based on WHO Database. Int J Gen Med. 2021;14:3909–3927. PubMed PMID: 34349544; PubMed Central PMCID: PMCPMC8326931; Eng.
   PubMedGoogle Scholar
• Baksi AJ, Kanaganayagam GS, Prasad SK. Arrhythmias in viral myocarditis and pericarditis. Card Electrophysiol Clin. 2015;7(2):269–281. PubMed PMID: 26002391; Eng.
   PubMedGoogle Scholar
• Alasady M, Shipp NJ, Brooks AG, et al. Myocardial Infarction and Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2013;6(4):738–745.
   PubMed Web of Science ®Google Scholar
• Cha YM, Redfield MM, Shen WK, et al. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation. 2004;109(23):2839–2843. PubMed PMID: 15197156; Eng.
   PubMed Web of Science ®Google Scholar
• Klein RM, Vester EG, Brehm MU, et al. Inflammation of the myocardium as an arrhythmia trigger. Zeitschrift fur Kardiologie. 2000;89 3:24–35. PubMed PMID: 10810782. Ger.
   PubMedGoogle Scholar
• Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997–4126. PubMed PMID: 36017572; Eng.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603–2615. PubMed PMID: 33301246; PubMed Central PMCID: PMCPMC7745181; Eng.
   PubMed Web of Science ®Google Scholar
• Athyros VG, Doumas M. A possible case of hypertensive crisis with intracranial haemorrhage after an mRNA Anti-COVID-19 Vaccine. Angiology. 2022;73(1):87. PubMed PMID: 34018416; Eng.
   PubMed Web of Science ®Google Scholar
• Bouhanick B, Montastruc F, Tessier S, et al. Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal. Eur J Clin Pharmacol. 2021;77(12):1937–1938. PubMed PMID: 34363519; Eng.
   PubMed Web of Science ®Google Scholar
• Meylan S, Livio F, Foerster M , et al. Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination.Hypertension. Hypertension. 2021;Vol. 77(6):e56–e57. PubMed PMID: 33764160; PubMed Central PMCID: PMCPMC8115421; Eng.
   Google Scholar
• Bouhanick B, Brusq C, Bongard V, et al. Blood pressure measurements after mRNA-SARS-CoV-2 tozinameran vaccination: a retrospective analysis in a university hospital in France. J Hum Hypertens. 2022;36(6):580–581.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Hypertension (Dallas, Tex: 1979). 2017;71(6):1269–1324. Hypertension (Dallas, Tex: 1979). 2018;PubMed PMID: 29133354; Eng
   Google Scholar
• Pelliccia F, Kaski JC, Crea F, et al. Pathophysiology of Takotsubo Syndrome. Circulation. 2017;135(24):2426–2441.
   PubMed Web of Science ®Google Scholar
• Singh K, Marinelli T, Horowitz JD. Takotsubo cardiomyopathy after anti-influenza vaccination: catecholaminergic effects of immune system. Am J Emerg Med. 2013;31(11):1627.e1–4. PubMed PMID: 23891597; Eng.
   PubMed Web of Science ®Google Scholar
• Crane P, Wong C, Mehta N, et al. Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination. BMJ Case Rep. 2021;14(10):e246580. PubMed PMID: 34625447; PubMed Central PMCID: PMCPMC8504353; Eng.
   PubMedGoogle Scholar
• Jani C, Leavitt J, Al Omari O, et al. COVID-19 Vaccine-Associated Takotsubo Cardiomyopathy. Am J Ther. 2021;28(3):361–364. PubMed PMID: 34375049; Eng.
   PubMed Web of Science ®Google Scholar
• de Chazal H M, Del Buono MG, Keyser-Marcus L, et al. Stress cardiomyopathy diagnosis and treatment: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018;72(16):1955–1971. PubMed PMID: 30309474; PubMed Central PMCID: PMCPMC7058348; Eng.
   PubMed Web of Science ®Google Scholar
• Publishing Service UK-G. COVID-19 mRNA Pfizer- BioNTech vaccine analysis print 2022 cited 2022 Dec 05]: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1072043/COVID-19_mRNA_Pfizer-_BioNTech_vaccine_analysis_print.pdf
   Google Scholar
• Vidula MK, Ambrose M, Glassberg H, et al. Myocarditis and other cardiovascular complications of the mRNA-Based COVID-19 Vaccines. Cureus. 2021;13(6):e15576. PubMed PMID: 34277198; PubMed Central PMCID: PMCPMC8270057; Eng.
   PubMed Web of Science ®Google Scholar
• Altarawneh HN, Chemaitelly H, Ayoub HH, et al. Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections. N Engl J Med. 2022;387(1):21–34. PubMed PMID: 35704396; PubMed Central PMCID: PMCPMC9258753; Eng.
   PubMed Web of Science ®Google Scholar
• Bozio CH, Grannis SJ, Naleway AL, et al. Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021. MMWR Morb Mortal Wkly Rep. 2021;70(44):1539–1544. PubMed PMID: 34735425; Eng.
   PubMedGoogle Scholar
• Advisory Committee on Immunization Practices (ACIP). ACIP evidence to recommendations for use of moderna COVID-19 vaccine in children ages 6 months – 5 years and pfizer-BioNTech COVID-19 vaccine in children ages 6 months – 4 years under an emergency use authorization. 2022. cited 2022 Dec 09]: https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-moderna-vaccine-6-17-years-etr.html
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Stay Up to Date with Your COVID-19 Vaccines. 2022. cited 2022 Dec 04]: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html#:~:text=CDC%20recommends%20COVID%2D19%20primary,%2D19%20vaccines%2C%20including%20boosters.
   Google Scholar
• United States Food and Drug Administration (FDA). Comirnaty and Pfizer-BioNTech COVID-19 Vaccine. 2022. cited 2022 Dec 03]: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/comirnaty-and-pfizer-biontech-covid-19-vaccine
   Google Scholar
• United States Food and Drug Administration (FDA). Spikevax and Moderna COVID-19 Vaccine. 2022. cited 2022 Dec 03: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/spikevax-and-moderna-covid-19-vaccine
   Google Scholar
• United States Food and Drug Administration (FDA). Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age. 2022. cited 2022 Dec 02: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-covid-19-vaccines-children#:~:text=For%20the%20Moderna%20COVID%2D19,years%20of%20age%20and%20older.
   Google Scholar
• Wallace M GJW, Hadler SC, Hadler SC, et al. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: update from the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2021;70(27):977–982.
   PubMed Web of Science ®Google Scholar
• Noh EB, Nam HK, Lee H. Which Group Should be Vaccinated First?: a Systematic Review. Infect Chemother. 2021;53(2):261–270. PubMed PMID: 34216120; PubMed Central PMCID: PMCPMC8258295; Eng.
   PubMed Web of Science ®Google Scholar
• Lobinska G, Pauzner A, Traulsen A, et al. Evolution of resistance to COVID-19 vaccination with dynamic social distancing. Nat Human Behav. 2022;6(2):193–206.
   PubMed Web of Science ®Google Scholar